Breaking News
5716 - 5730 of 6634 results
March 28, 2007
PPD, Inc. has opened offices in Athens, Greece, and Seattle, WA, in an effort to expand its global footprint for clinical development services. Both offices serve as hubs for previously regional-based employees in providing development services for P…
Read More »
March 28, 2007
Perrigo Company has restructured in an effort to enhance the management of the company's global operations. John Hendrickson has been named executive vice president of global operations and supply chain. Mr. Hendrickson will be responsible for the gl…
Read More »
March 27, 2007
Microtest has signed an agreement with UK-based biopharmaceutical company Antisoma to begin the aseptic manufacturing of AS1411, a new drug being developed for the treatment of various cancers. Under the terms of the agreement, Microtest will be resp…
Read More »
March 27, 2007
Barrier Therapeutics achieved positive results from its Phase IIb dose ranging study for its antifungal candidate pramiconazole (previously known as Azoline). Pramiconazole met the primary endpoint of effectively treating tinea (pityriasis) versicolo…
Read More »
March 27, 2007
AppTec and Boehringer Ingelheim's first year of partnering is providing enhanced capabilities and a smooth transition to large-scale manufacturing for clients, according to the companies. Last spring, AppTec announced that Boehringer Ingelheim had be…
Read More »
March 26, 2007
Comar, Inc. has plans to sell its glass manufacturing operation, with the exception of its glass pipette manufacturing business, to Gerresheimer's Kimble Glass, Inc. Terms of the agreement were not disclosed. The closing of the transaction is expecte…
Read More »
March 26, 2007
DSM Biologics and Crucell N.V. have signed a non-exclusive PER.C6 research licensing deal with Taipei, Taiwan-headquartered Development Center for Biotechnology (DCB). DCB will use the human cell line for its in-house production of undisclosed recomb…
Read More »
March 26, 2007
Merck has entered an agreement to begin development of a Zetia and Lipitor combination product in collaboration with Schering-Plough. The Merck/SP Pharmaceuticals joint venture was formed in 2000 to develop and market new medicines in the U.S. in cho…
Read More »
March 26, 2007
The European Commission has approved Merck's Januvia, a once-daily oral treatment for patients with type 2 diabetes. Januvia is the first medication in a new class of drugs known as dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors), which enhance…
Read More »
March 23, 2007
Charles River Laboratories International, Inc. has plans to expand its global footprint in Asia as part of its strategy to support customers' R&D efforts in this growing market. The first phase of expansion includes the signing of a joint venture…
Read More »
March 23, 2007
Analytical Bio-Chemistry Laboratories (ABC) broke ground for its new lab facility in MO. The $14.4 million, 90,000 sq.-ft. facility will house the company's growing pharmaceutical development business and will more than double its capacity. Last May,…
Read More »
March 23, 2007
C. Richard Piazza has been appointed chief executive officer of Chemokine Therapeutics Corp. Mr. Piazza succeeds Dr. Hassan Salari who held the position since he founded the company in 1998. Dr. Salari will continue to serve as president and his role…
Read More »
March 22, 2007
Eisai Co., Ltd., Eisai Corp. of North America (ECA), has signed a definitive agreement to acquire Morphotek, Inc. for $325 million in cash.
Morphotek develops therapeutic monoclonal antibodies through the use of proprietary human antibody techno…
Read More »
March 22, 2007
Vion Pharmaceuticals has extended its agreement with SAFC Pharma for the manufacture of the API in Cloretazine, an anti-cancer drug currently in a Phase III trial in combination with Ara-C for relapsed acute myelogenous leukemia (AML), and a Phase II…
Read More »
March 22, 2007
The Dow Chemical Co. has entered a strategic alliance with Colorcon, Inc. for the global marketing, sales, technical service and development, and distribution of Dow's excipient products for use in controlled release applications. The agreement appli…
Read More »
5716 - 5730 of 6634 results
